Equities

Transcat Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Transcat Inc

Actions
  • Price (EUR)64.50
  • Today's Change-2.50 / -3.73%
  • Shares traded0.00
  • 1 Year change-15.13%
  • Beta0.7370
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. It is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. It provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.

  • Revenue in USD (TTM)319.69m
  • Net income in USD7.89m
  • Incorporated1964
  • Employees1.25k
  • Location
    Transcat Inc35 Vantage Point DrROCHESTER 14624United StatesUSA
  • Phone+1 (585) 352-7777
  • Fax+1 (585) 352-1486
  • Websitehttps://www.transcat.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TRNS:NMQ since
announced
Transaction
value
Walsh Engineering Services Inc-Essco Calibration LaboratoryDeal completed05 Aug 202505 Aug 2025Deal completed4.40%84.00m
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.